 |
Allogeneic donor-derived ex-vivo expanded T lymphocytes transduced with a retroviral vector containing inducible caspase 9 and truncated CD19 |
|---|---|
| Trade Name | |
| Orphan Indication | Treatment in haematopoietic stem cell transplantation |
| EU Market Approval | EU |
| EU Designation Date | 2016-06-27 00:00:00 |
| Sponsor | Bellicum Pharma Limited |
